Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
18.98
+0.67 (3.66%)
Nov 5, 2024, 3:49 PM EST - Market open
CRBP Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Cash & Equivalents | 23.69 | 13.72 | 17 | 25.01 | 85.43 | 31.75 | Upgrade
|
Short-Term Investments | 123.34 | 7.18 | 42.19 | 72.64 | - | - | Upgrade
|
Cash & Short-Term Investments | 147.03 | 20.91 | 59.2 | 97.65 | 85.43 | 31.75 | Upgrade
|
Cash Growth | 302.08% | -64.68% | -39.38% | 14.30% | 169.09% | -23.95% | Upgrade
|
Accounts Receivable | - | - | - | - | 1.62 | 2.68 | Upgrade
|
Other Receivables | - | - | - | - | 0.96 | - | Upgrade
|
Receivables | - | - | - | - | 2.58 | 2.68 | Upgrade
|
Prepaid Expenses | 1 | 2.45 | 0.79 | 2.37 | 3.71 | 3.72 | Upgrade
|
Restricted Cash | 0.29 | 0.19 | 0.19 | 0.19 | 0.35 | - | Upgrade
|
Total Current Assets | 148.31 | 23.55 | 60.18 | 100.2 | 92.07 | 38.15 | Upgrade
|
Property, Plant & Equipment | 3.28 | 4.04 | 5.5 | 7 | 9.32 | 10.9 | Upgrade
|
Other Long-Term Assets | 0.39 | 0.69 | 0.63 | 0.52 | 0.9 | 0.08 | Upgrade
|
Total Assets | 151.98 | 28.27 | 66.31 | 107.73 | 102.29 | 49.14 | Upgrade
|
Accounts Payable | 1.15 | 3.18 | 2.17 | 1.78 | 7.38 | 11.09 | Upgrade
|
Accrued Expenses | 10.49 | 11.03 | 6 | 10.09 | 22.01 | 22.45 | Upgrade
|
Current Portion of Long-Term Debt | 10.82 | 16.21 | 3.15 | 3.86 | 0.71 | 0.75 | Upgrade
|
Current Portion of Leases | 1.52 | 1.44 | 1.28 | 1.14 | 1 | 0.6 | Upgrade
|
Other Current Liabilities | - | 0.04 | 0.04 | 0.13 | 0.8 | - | Upgrade
|
Total Current Liabilities | 23.98 | 31.89 | 12.64 | 17.01 | 31.9 | 34.89 | Upgrade
|
Long-Term Debt | - | - | 15.98 | 15.64 | 18.03 | - | Upgrade
|
Long-Term Leases | 2.46 | 3.24 | 4.68 | 5.96 | 7.09 | 8.1 | Upgrade
|
Other Long-Term Liabilities | - | 0.04 | 0.02 | 0.02 | - | - | Upgrade
|
Total Liabilities | 26.44 | 35.18 | 33.32 | 38.62 | 57.02 | 42.98 | Upgrade
|
Common Stock | 0 | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
Additional Paid-In Capital | 579.51 | 429.78 | 425.2 | 418.9 | 349.36 | 198.98 | Upgrade
|
Retained Earnings | -453.58 | -436.68 | -392.08 | -349.73 | -304.09 | -192.82 | Upgrade
|
Comprehensive Income & Other | -0.39 | -0 | -0.13 | -0.06 | - | - | Upgrade
|
Total Common Equity | 125.54 | -6.9 | 32.99 | 69.11 | 45.27 | 6.16 | Upgrade
|
Shareholders' Equity | 125.54 | -6.9 | 32.99 | 69.11 | 45.27 | 6.16 | Upgrade
|
Total Liabilities & Equity | 151.98 | 28.27 | 66.31 | 107.73 | 102.29 | 49.14 | Upgrade
|
Total Debt | 14.8 | 20.88 | 25.09 | 26.59 | 26.84 | 9.45 | Upgrade
|
Net Cash (Debt) | 132.23 | 0.02 | 34.11 | 71.06 | 58.6 | 22.3 | Upgrade
|
Net Cash Growth | 929.28% | -99.94% | -52.00% | 21.26% | 162.73% | -46.07% | Upgrade
|
Net Cash Per Share | 18.75 | 0.01 | 8.18 | 17.35 | 22.50 | 10.47 | Upgrade
|
Filing Date Shares Outstanding | 12.04 | 10.49 | 4.17 | 4.17 | 4.17 | 2.42 | Upgrade
|
Total Common Shares Outstanding | 11.5 | 4.42 | 4.17 | 4.17 | 3.3 | 2.16 | Upgrade
|
Working Capital | 124.33 | -8.35 | 47.54 | 83.2 | 60.18 | 3.27 | Upgrade
|
Book Value Per Share | 10.92 | -1.56 | 7.91 | 16.56 | 13.74 | 2.86 | Upgrade
|
Tangible Book Value | 125.54 | -6.9 | 32.99 | 69.11 | 45.27 | 6.16 | Upgrade
|
Tangible Book Value Per Share | 10.92 | -1.56 | 7.91 | 16.56 | 13.74 | 2.86 | Upgrade
|
Machinery | 1.2 | 1.2 | 1.38 | 1.43 | 2.25 | 2.34 | Upgrade
|
Leasehold Improvements | 3.33 | 3.33 | 3.33 | 3.33 | 4.16 | 4.15 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.